Wait goes on for regulation in South Africa
This article was originally published in SRA
Executive Summary
The promise of a system of device and in vitro diagnostics regulation is still very much alive in South Africa, even if the timelines remain sketchy.
You may also be interested in...
South Africa Medtech Regulations Published – Vital Next Steps Still Awaited
South Africa's new regulatory system has taken another step forward, but, it appears, also one to the side, in a move that observers fear will add extra time to the overall process of getting the country's first medtech-only system fully up and running.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.